Access the full text.
Sign up today, get DeepDyve free for 14 days.
Pharm. students, authored seven books in pharmaceutical sciences, and contributed chapters to the several international books
Nusrat Motlekar, A. Fasano, M. Wachtel, B. Youan (2006)
RETRACTED: Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparinJournal of Drug Targeting, 14
A. Leone-Bay, D. Paton, J. Weidner (2000)
The Development of Delivery Agents that Facilitate the Oral Absorption of Macromolecular DrugsMedicinal Research Reviews, 20
S. Berkowitz, V. Marder, G. Košutić, R. Baughman (2003)
Oral heparin administration with a novel drug delivery agent (SNAC) in healthy volunteers and patients undergoing elective total hip arthroplastyJournal of Thrombosis and Haemostasis, 1
Benjamin Ross, I. Toth (2005)
Gastrointestinal absorption of heparin by lipidization or coadministration with penetration enhancers.Current drug delivery, 2 3
Rishi Paliwal, S. Paliwal, N. Mishra, Abhinav Mehta, S. Vyas (2009)
Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate.International journal of pharmaceutics, 380 1-2
D. Whelan, H. Beusekom, W. Giessen (1998)
Mechanisms of drug loading and release kinetics.Seminars in interventional cardiology : SIIC, 3 3-4
D. Tollefsen, D. Majerus, M. Blank (1982)
Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma.The Journal of biological chemistry, 257 5
Yong-kyu Lee, S. Kim, Y. Byun (2000)
Oral Delivery of New Heparin Derivatives in RatsPharmaceutical Research, 17
Lei Jin, J. Abrahams, J. Abrahams, R. Skinner, M. Petitou, R. Pike, R. Carrell (1997)
The anticoagulant activation of antithrombin by heparin.Proceedings of the National Academy of Sciences of the United States of America, 94 26
A. Bernkop‐Schnürch, C. Kast, D. Guggi (2003)
Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems.Journal of controlled release : official journal of the Controlled Release Society, 93 2
Y. Park, Jun Liang, Hui Song, Y. Li, S. Naik, V. Yang (2003)
ATTEMPTS: a heparin/protamine-based triggered release system for the delivery of enzyme drugs without associated side-effects.Advanced drug delivery reviews, 55 2
Marie-Hélène Dufresne, J. Leroux (2004)
Study of the Micellization Behavior of Different Order Amino Block Copolymers with HeparinPharmaceutical Research, 21
S. Lanke, S. Gayakwad, J. Strom, M. D'souza (2009)
Oral delivery of low molecular weight heparin microspheres prepared using biodegradable polymer matrix systemJournal of Microencapsulation, 26
A. Bernkop‐Schnürch, M. Hoffer, K. Kafedjiiski (2004)
Thiomers for oral delivery of hydrophilic macromolecular drugsExpert Opinion on Drug Delivery, 1
G. Gatti, B. Casu*, G. Hamer, A. Perlin (1979)
Studies on the Conformation of Heparin by 1H and 13C NMR SpectroscopyMacromolecules, 12
Y. Lee, J. Nam, Ho-Chul Shin, Y. Byun (2001)
Conjugation of Low-Molecular-Weight Heparin and Deoxycholic Acid for the Development of a New Oral Anticoagulant AgentCirculation: Journal of the American Heart Association, 104
S. Kim, B. Vaishali, Eunhye Lee, Seulki Lee, Yong-kyu Lee, T. Kumar, H. Moon, Y. Byun (2006)
Oral delivery of chemical conjugates of heparin and deoxycholic acid in aqueous formulation.Thrombosis research, 117 4
S. Money, J. York (2001)
Development of oral heparin therapy for prophylaxis and treatment of deep venous thrombosis.Cardiovascular surgery, 9 3
V. Hoffart, N. Ubrich, A. Lamprecht, K. Bachelier, C. Vigneron, T. Lecompte, M. Hoffman, P. Maincent (2003)
Microencapsulation of Low Molecular Weight Heparin into Polymeric Particles Designed with Biodegradable and Nonbiodegradable Polycationic PolymersDrug Delivery, 10
J. Weitz (2004)
New Anticoagulants for Treatment of Venous ThromboembolismCirculation, 110
A. Leone-Bay, D. Paton, B. Variano, H. Leipold, T. Rivera, J. Miura-Fraboni, R. Baughman, N. Santiago (1998)
Acylated non-α-amino acids as novel agents for the oral delivery of heparin sodium, USPJournal of Controlled Release, 50
Mei-Chin Chen, Hen-Sheng Wong, Kun-Ju Lin, Hsin‐Lung Chen, S. Wey, K. Sonaje, Yu-Hsin Lin, C. Chu, Hsing‐Wen Sung (2009)
The characteristics, biodistribution and bioavailability of a chitosan-based nanoparticulate system for the oral delivery of heparin.Biomaterials, 30 34
J. Weitz, E. Young, M. Johnston, A. Stafford, J. Fredenburgh, J. Hirsh (1999)
Vasoflux, a new anticoagulant with a novel mechanism of action.Circulation, 99 5
K. Salartash, M. Gonze, A. Leone-Bay, R. Baughman, W. Sternbergh, S. Money (1999)
Oral low-molecular weight heparin and delivery agent prevents jugular venous thrombosis in the rat.Journal of vascular surgery, 30 3
A. Leone-Bay, D. Paton, J. Freeman, C. Lercara, D. O'toole, D. Gschneidner, E. Wang, E. Harris, C. Rosado, T. Rivera, A. DeVincent, M. Tai, F. Mercogliano, R. Agarwal, H. Leipold, R. Baughman (1998)
Synthesis and evaluation of compounds that facilitate the gastrointestinal absorption of heparin.Journal of medicinal chemistry, 41 7
C. Hwang, David Wu, E. Edelman (2001)
Physiological Transport Forces Govern Drug Distribution for Stent-Based DeliveryCirculation: Journal of the American Heart Association, 104
Nusrat Motlekar, K. Srivenugopal, M. Wachtel, B. Youan (2005)
RETRACTED: Oral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levelsJournal of Drug Targeting, 13
Dmitry Malkov, Huai-zhen Wang, S. Dinh, I. Gómez-Orellana (2002)
Pathway of Oral Absorption of Heparin with Sodium N-[8-(2-Hydroxybenzoyl)Amino]CaprylatePharmaceutical Research, 19
Y. Jiao, N. Ubrich, M. Marchand-Arvier, C. Vigneron, M. Hoffman, T. Lecompte, P. Maincent (2002)
In Vitro and In Vivo Evaluation of Oral Heparin–Loaded Polymeric Nanoparticles in RabbitsCirculation: Journal of the American Heart Association, 105
L. Jaques (1979)
Heparins--anionic polyelectrolyte drugs.Pharmacological reviews, 31 2
Arbit (2006)
Oral heparin: Status reviewThromb J, 4
L. Borsig (2004)
Selectins facilitate carcinoma metastasis and heparin can prevent them.News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society, 19
J. Dunn, A. Hollister (1995)
Oral biovailability of heparin using a novel delivery systemCurrent Therapeutic Research-clinical and Experimental, 56
Y. Pellequer, Y. Meissner, N. Ubrich, A. Lamprecht (2007)
Epithelial Heparin Delivery via Microspheres Mitigates Experimental Colitis in MiceJournal of Pharmacology and Experimental Therapeutics, 321
L. Hiebert (2002)
Oral heparins.Clinical laboratory, 48 3-4
M. Thanou, S. Henderson, A. Kydonieus, Clive Elson (2007)
N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.Journal of controlled release : official journal of the Controlled Release Society, 117 2
R. Medina, Denise Foto (2004)
The use of bivalirudin to prevent subacute thrombosis during drug-eluting stent implantation.The Journal of invasive cardiology, 16 5
C. Kast, D. Guggi, N. Langoth, A. Bernkop‐Schnürch (2003)
Development and in Vivo Evaluation of an Oral Delivery System for Low Molecular Weight Heparin Based on Thiolated PolycarbophilPharmaceutical Research, 20
Michael Goldberg, I. Gómez-Orellana (2003)
Challenges for the oral delivery of macromoleculesNature Reviews Drug Discovery, 2
J. Arnold, F. Ahsan, E. Meezan, D. Pillion (2002)
Nasal administration of low molecular weight heparin.Journal of pharmaceutical sciences, 91 7
A. Lamprecht, N. Ubrich, P. Maincent (2007)
Oral low molecular weight heparin delivery by microparticles from complex coacervation.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 67 3
M. Perretti, C. Page (2000)
Heparin and inflammation: a new use for an old GAG?Gut, 47
P. Hayes, Benjamin Ross, Bradley Thomas, I. Toth (2006)
Polycationic lipophilic-core dendrons as penetration enhancers for the oral administration of low molecular weight heparin.Bioorganic & medicinal chemistry, 14 1
Robert Baughman, S. Kapoor, Rajesh Agarwal, James Kisicki, F. Catella-Lawson, Garret Fitzgerald (1998)
Oral delivery of anticoagulant doses of heparin. A randomized, double-blind, controlled study in humans.Circulation, 98 16
S. Kim, Dong Lee, Eunhye Lee, Yong-kyu Lee, Choong‐Yong Kim, H. Moon, Y. Byun (2007)
Absorption study of deoxycholic acid-heparin conjugate as a new form of oral anti-coagulant.Journal of controlled release : official journal of the Controlled Release Society, 120 1-2
Shuhua Bai, F. Ahsan (2009)
Synthesis and Evaluation of Pegylated Dendrimeric Nanocarrier for Pulmonary Delivery of Low Molecular Weight HeparinPharmaceutical Research, 26
S. Kim, Eun Lee, B. Vaishali, Seulki Lee, Y. Lee, Choong‐Yong Kim, H. Moon, Y. Byun (2005)
Tricaprylin microemulsion for oral delivery of low molecular weight heparin conjugates.Journal of controlled release : official journal of the Controlled Release Society, 105 1-2
Yukako Ito, Tomohiro Kusawake, Y. Prasad, N. Sugioka, N. Shibata, K. Takada (2006)
Preparation and evaluation of oral solid heparin using emulsifier and adsorbent for in vitro and in vivo studies.International journal of pharmaceutics, 317 2
Dong Lee, Jisook Lee, Seulki Lee, S. Kim, Y. Byun (2007)
Liphophilic complexation of heparin based on bile acid for oral delivery.Journal of controlled release : official journal of the Controlled Release Society, 123 1
A. Pozzo, M. Acquasaliente, M. Geron, G. Andriuoli (1989)
New heparin complexes active by intestinal absorption: I-multiple ion pairs with basic organic compounds.Thrombosis research, 56 1
L. Bergamaschini, Emanuela Rossi, C. Storini, S. Pizzimenti, M. Distaso, C. Perego, A. Luigi, C. Vergani, M. Simoni (2004)
Peripheral Treatment with Enoxaparin, a Low Molecular Weight Heparin, Reduces Plaques and β-Amyloid Accumulation in a Mouse Model of Alzheimer's DiseaseThe Journal of Neuroscience, 24
G. Pineo, R. Hull, V. Marder (2001)
Orally active heparin and low–molecular-weight heparinCurrent Opinion in Pulmonary Medicine, 7
T. Leonard, John Lynch, M. McKenna, David Brayden (2006)
Promoting absorption of drugs in humans using medium-chain fatty acid-based solid dosage forms: GIPET™Expert Opinion on Drug Delivery, 3
Yong-kyu Lee, S. Kim, Dong Lee, Seulki Lee, Choong‐Yong Kim, Ho-Chul Shin, H. Moon, Y. Byun (2006)
Efficacy of orally active chemical conjugate of low molecular weight heparin and deoxycholic acid in rats, mice and monkeys.Journal of controlled release : official journal of the Controlled Release Society, 111 3
A. Bentolila, I. Vlodavsky, Christine Haloun, A. Domb (2000)
Synthesis and heparin-like biological activity of amino acid-based polymersPolymers for Advanced Technologies, 11
Hua-Jie Wang, Zhi-xin Lin, Xin-ming Liu, Shilong Sheng, Jin-Ye Wang (2005)
Heparin-loaded zein microsphere film and hemocompatibility.Journal of controlled release : official journal of the Controlled Release Society, 105 1-2
T. Schmitz, V. Leitner, A. Bernkop‐Schnürch (2005)
Oral heparin delivery: design and in vivo evaluation of a stomach-targeted mucoadhesive delivery system.Journal of pharmaceutical sciences, 94 5
L. Bergamaschini, C. Donarini, Emanuela Rossi, A. Luigi, C. Vergani, M. Simoni (2002)
Heparin attenuates cytotoxic and inflammatory activity of Alzheimer amyloid-β in vitroNeurobiology of Aging, 23
L. Lam, J. Silbert, R. Rosenberg (1976)
The separation of active and inactive forms of heparin.Biochemical and biophysical research communications, 69 2
K. Salartash, M. Lepore, M. Gonze, A. Leone-Bay, R. Baughman, W. Sternbergh, J. Bowen, S. Money (2000)
Treatment of experimentally induced caval thrombosis with oral low molecular weight heparin and delivery agent in a porcine model of deep venous thrombosis.Annals of surgery, 231 6
G. Pineo, R. Hull, V. Marder (2004)
Oral delivery of heparin: SNAC and related formulations.Best practice & research. Clinical haematology, 17 1
(2005)
Thrombosis Journal BioMed Central
Nusrat Motlekar, B. Youan (2006)
The quest for non-invasive delivery of bioactive macromolecules: a focus on heparins.Journal of controlled release : official journal of the Controlled Release Society, 113 2
M. Gonze, J. Manord, A. Leone-Bay, R. Baughman, C. Garrard, W. Sternbergh, S. Money (1998)
Orally administered heparin for preventing deep venous thrombosis.American journal of surgery, 176 2
L. Borsig, Richard Wong, J. Feramisco, David Nadeau, N. Varki, A. Varki (2001)
Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasisProceedings of the National Academy of Sciences of the United States of America, 98
R. Linhardt (2004)
Heparin-induced cancer cell death.Chemistry & biology, 11 4
(2006)
Thrombosis Journal BioMed Central Review Oral heparin: status review
Anita Thomas, Julie Campbell (2004)
Targeted delivery of heparin and LMWH using a fibrin antibody prevents restenosis.Atherosclerosis, 176 1
E. Windsor, L. Freeman (1964)
AN INVESTIGATION OF ROUTES OF ADMINISTRATION OF HEPARIN OTHER THAN INJECTION.The American journal of medicine, 37
J. Hirsh, T. Warkentin, R. Raschke, C. Granger, E. Ohman, J. Dalen (1998)
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.Chest, 114 5 Suppl
T. Rivera, A. Leone-Bay, D. Paton, H. Leipold, R. Baughman (1997)
Oral Delivery of Heparin in Combination with Sodium N-[8-(2-Hydroxybenzoyl)amino]caprylate: Pharmacological ConsiderationsPharmaceutical Research, 14
Nusrat Motlekar, K. Srivenugopal, M. Wachtel, B. Youan (2006)
Evaluation of the oral bioavailability of low molecular weight heparin formulated with glycyrrhetinic acid as permeation enhancerDrug Development Research, 67
Y. Meissner, N. Ubrich, F. Ghazouani, P. Maincent, A. Lamprecht (2007)
Low molecular weight heparin loaded pH-sensitive microparticles.International journal of pharmaceutics, 335 1-2
T. Chandy, G. Rao, Robert Wilson, G. Das (2002)
Delivery of LMW Heparin via Surface Coated Chitosan/peg-Alginate Microspheres Prevents ThrombosisDrug Delivery, 9
L. Andersson, T. Barrowcliffe, E. Holmer, E. Johnson, G. Sims (1976)
Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration.Thrombosis research, 9 6
V. Hoffart, A. Lamprecht, P. Maincent, T. Lecompte, C. Vigneron, N. Ubrich (2006)
Oral bioavailability of a low molecular weight heparin using a polymeric delivery system.Journal of controlled release : official journal of the Controlled Release Society, 113 1
Unfractionated heparin (UFH) and low‐molecular‐weight heparin (LMWH) are first choices of clinicians among available anticoagulants. Currently, these agents are administered either parenterally or subcutaneously, which reduces patient compliance and acceptability. Oral heparin may serve as an alternative to both parenteral heparin as well as presently available oral anticoagulants such as warfarin. This review focuses mainly upon recent perspectives in the development of heparin as an oral anticoagulant. The possibility of its success with special emphasis to nanotechnological approaches has been elaborated. Important strategies such as the use of penetration enhancers, the development of lipid conjugates of heparin, and the incorporation of heparin in polymeric matrix systems have been discussed. Additionally, introductory information on biological activities, physiochemical aspects, and pharmacokinetic and pharmacodynamic parameters of heparin is summarized. A brief comparison of UFH and LMWH is also included for reader's benefit. Informative discussion on clinical trials with the successes and limitations of oral heparin formulations is also presented. Overall, the present review provides complete insight to the research that has been carried out for the development of heparin as oral anticoagulant. © 2011 Wiley Periodicals, Inc. Med Res Rev
Medicinal Research Reviews – Wiley
Published: Jan 1, 2012
Keywords: ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.